top of page
Browse by category
Search
Palatin initiates study of bremelanotide for the treatment of obesity
Palatin Technologies has begun a Phase 2 clinical study of bremelanotide for the treatment of obesity. The clinical study will evaluate...
GLP-1 medications for teens with type 2 diabetes and obesity frequently denied by insurance companies
Health insurance companies often deny coverage for GLP-1 receptor agonists (GLP1Ra) that treat children and teens with obesity and type 2...
Increased risk of heart attack and stroke for people living with obesity for a decade or more
People under age 50 have a greater risk for heart attack or stroke if they've lived with obesity for ten years, according to a study...
New drug candidate targeting mitochondria reverses obesity in mice
Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells'...
Researchers identify Brown adipose tissue’s 'off-switch'
Professor Jan-Wilhelm Kornfeld from the University of Southern Denmark/the Novo Nordisk Center for Adipocyte Signaling (Adiposign) and...
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity
Eli Lilly and Company has announced positive topline results from the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide...
Ultra-processed foods increase the risk of all-cause mortality and to 32 damaging health outcomes
Highly suggestive (class II) evidence indicates that higher exposure to ultra-processed foods is associated with an increased risk of 32...
Disrupted cellular function of “cleaning cells” may explain why some people with obesity develop T2DM
Disrupted function of “cleaning cells” in the body may help to explain why some people with obesity develop type 2 diabetes, while others...
The role of growth hormone secretagogue receptor in obesity-related chronic inflammation
A team comprised primarily of Texas A&M AgriLife Research scientists has made an important discovery that could lead to a novel treatment...
Individuals with obesity are more likely to have benign blood condition MGUS
Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that...
Browse by tag
bottom of page